loading

Century Therapeutics Inc Azioni (IPSC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
54.23%
36.53
23.68 36.12 34.66 34.99
Operating Income/Loss
54.23%
-36.53
-23.68 -36.12 -34.66 74.18
Nonoperating Income/Loss
3.04%
1.977
2.039 1.702 2.123 2.384
Net Income/Loss
59.62%
-34.55
-21.64 -34.42 -32.54 76.56
Basic Average Shares
6.36%
205.78
193.47 86.46 86.24 86.02
Diluted Average Shares
6.36%
205.78
193.47 86.46 86.24 86.10
Basic Earnings Per Share
54.55%
-0.17
-0.11 -0.40 -0.38 0.89
Diluted Earnings Per Share
54.55%
-0.17
-0.11 -0.40 -0.38 0.89
$5.85
price down icon 0.85%
$8.095
price up icon 3.92%
$8.375
price up icon 0.06%
$11.86
price down icon 6.06%
DNA DNA
$9.73
price down icon 2.80%
$10.49
price down icon 2.24%
Capitalizzazione:     |  Volume (24 ore):